Article
Expression of a mutant DNA topoisomerase II in CCRF-CEM human leukemic cells selected for resistance to teniposide.
Proceedings of the National Academy of Sciences of the United States of America - 1 Sept 1991
Bugg B Y, Danks M K, Beck W T, Suttle D P
Abstract excerpt
Nuclear extracts from teniposide (VM-26)-resistant sublines of the human leukemic cell line CCRF-CEM have decreased levels of DNA topoisomerase II catalytic activity and decreased capacity to form drug-stabilized covalent protein-DNA complexes. The ATP concentration required for equivalent activi...
Topics
- Alleles
- Amino Acid Sequence
- Animals
- Base Sequence
- Cloning, Molecular
- DNA Topoisomerases, Type II
- Drug Resistance
- Gene Expression
- Humans
- Molecular Sequence Data
- Mutation
- Oligonucleotide Probes
